Company / Tangible Book Value per Share
Fulcrum Therapeutics, Inc. Tangible Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$5508.64
FY2025
5-year range
$3836.13 / $5982.27
FY2021-FY2025
Trend
+40.5%
vs FY2024
Sector context
#2 of 209
Health Care
What the data says
Among 209 Health Care companies, Fulcrum Therapeutics, Inc. is in the top 1% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 8 years, ranging from $-50652.35 in FY2018 to $7890.01 in FY2019.
Based on SEC 10-K filings.
5508.64 in FY2025 with a 5-year CAGR of +8.0%. Ranks 2nd among 209 companies in Health Care.
Improved from $3836.13 to $5508.64 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Sector benchmark
+5793.8% above sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 40.5% year-over-year.
- Ranks #2 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.44 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5508.64 | +40.5% |
| FY2024 | $3920.92 | +2.2% |
| FY2023 | $3836.13 | -13.2% |
| FY2022 | $4421.82 | -26.1% |
| FY2021 | $5982.27 | +59.4% |
| FY2020 | $3754.08 | -52.4% |
| FY2019 | $7890.01 | +115.6% |
| FY2018 | -$50652.35 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026